Approval · Notice of Compliance 22113 · 2019
VIBERZI: Notice of Compliance 22113
Issued April 29, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22113
- Date
- April 29, 2019
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
Medicinal ingredients
- ELUXADOLINE 75 MG per TAB
- ELUXADOLINE 100 MG per TAB